Overview

Pilot Study of Sedation With Propofol in Refractory Pains Due to Care in Palliative Care Unit

Status:
Unknown status
Trial end date:
2016-02-01
Target enrollment:
0
Participant gender:
All
Summary
In the palliative care unit, certain patients suffer from pain associated with medical procedures/care which is poorly controlled by antalgics. These situations may necessitate temporary sedation to improve comfort and facilitate treatment. No proven consensus exists, either in the literature or in clinical studies conducted, on the choice of sedative agent however Midazolam is the general recommendation. The investigators believe that Propofol could be used in this instance
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Treatments:
Propofol
Criteria
Inclusion Criteria:

- patients hospitalized in palliative care unit

- dying terminally patients

- pains resisting to fentanyl and MEOPA (Melange equimolaire Oxygène protocyde d'Azote)
(EMONO = equimolar mixture of oxygene and nitrous oxide)

Exclusion Criteria:

- contra-indication to soya

- contra-indication to egg lecithin

- Respiratory insufficiency